| Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Model 1 | Model 2 | |||||
Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | |
Sex | 0.80 (0.49, 1.34) | 0.39 | 0.70 (0.40, 1.22) | 0.21 | 0.61 (0.34, 1.07) | 0.09 |
Age (10Â years) | 1.18 (1.01, 1.38) | 0.04 | 1.03 (0.87, 1.24) | 0.70 | 1.04 (0.87, 1.24) | 0.68 |
DAS28-CRP-based non-remission | 2.37 (1.47, 3.82) |  < 0.01 | 1.45 (0.81, 2.61) | 0.22 |  |  |
TJC | 1.10 (0.97, 1.25) | 0.14 | Â | Â | 0.96 (0.81, 1.14) | 0.63 |
SJC | 1.06 (0.92, 1.21) | 0.40 | Â | Â | 0.94 (0.78, 1.14) | 0.55 |
CRP | 1.01 (0.74, 0.99) | 0.96 | Â | Â | 0.71 (0.50, 1.01) | 0.06 |
PtGA (0–10) | 1.27 (1.17, 1.38) |  < 0.01 |  |  | 1.21 (1.09, 1.35) |  < 0.01 |
HAQ-DI non-remission | 2.96 (1.96, 4.53) |  < 0.01 | 2.65 (1.56, 4.50) |  < 0.01 | 1.95 (1.15, 3.31) | 0.01 |
Pain VAS (0–10) | 1.13 (1.05, 1.22) |  < 0.01 | 0.98 (0.88, 1.09) | 0.77 |  |  |
Biological DMARDs | 0.92 (0.61, 1.37) | 0.68 | 0.84 (0.53, 1.33) | 0.45 | 0.88 (0.55, 1.40) | 0.58 |
Methotrexate | 0.60 (0.40, 0.90) | 0.01 | 0.72 (0.45, 1.14) | 0.16 | 0.76 (0.48, 1.22) | 0.26 |
Steroid | 1.87 (1.24, 2.81) |  < 0.01 | 1.48 (0.93, 2.34) | 0.09 | 1.66 (1.03, 2.67) | 0.04 |